Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.38 USD | -3.26% | -13.93% | -29.88% |
May. 09 | Intellia Therapeutics' Q1 Net Loss Narrows, Collaboration Revenue Rises | MT |
May. 09 | Transcript : Intellia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
INTELLIA THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -3.26% | -13.93% | -29.88% | -42.62% | +54.03% | 2.06B |
- Stock Market
- Equities
- NTLA Stock
- Charts Intellia Therapeutics, Inc.
- Relative Strength Chart